Publication: Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
Loading...
Identifiers
Date
2018-08-01
Authors
Turner, Dan
Ruemmele, Frank M
Orlanski-Meyer, Esther
Griffiths, Anne M
de Carpi, Javier Martin
Bronsky, Jiri
Veres, Gabor
Aloi, Marina
Strisciuglio, Caterina
Braegger, Christian P
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Abstract
Background: The contemporary management of ambulatory ulcerativecolitis (UC) continues to be challenging with 20% of children needinga colectomy within childhood years. We thus aimed to standardize dailytreatment of pediatric UC and inflammatory bowel diseases (IBD)-unclas-sified through detailed recommendations and practice points.
Methods: These guidelines are a joint effort of the European Crohn’s andColitis Organization (ECCO) and the Paediatric IBD Porto group of EuropeanSociety of Paediatric Gastroenterology, Hepatology and Nutrition(ESPGHAN). An extensive literature search with subsequent evidenceappraisal using robust methodology was performed before 2 face-to-facemeetings. All 40 included recommendations and 86 practice points wereendorsed by 43 experts in Paediatric IBD with at least an 88% consensus rate.
Results: These guidelines discuss how to optimize the use of mesalamine(including topical), systemic and locally active steroids, thiopurines and, formore severe disease, biologics. The use of other emerging therapies and therole of surgery are also covered. Algorithms are provided to aid therapeuticdecision-making based on clinical assessment and the Paediatric UC ActivityIndex (PUCAI). Advice on contemporary therapeutic targets incorporatingthe use of calprotectin and the role of therapeutic drug monitoring arepresented, as well as other management considerations around pouchitis,extraintestinal manifestations, nutrition, growth, psychology, and transition.A brief section on disease classification using the PIBD-classes criteria andIBD-unclassified is also part of these guidelines.
Conclusions: These guidelines provide a guide to clinicians managing childrenwith UC and IBD-unclassified management to provide modern management stra-tegies while maintaining vigilance around appropriate outcomes and safety issues.
Description
MeSH Terms
Ambulatory Care
Child
Child Nutritional Physiological Phenomena
Colitis, Ulcerative
Europe
Female
Humans
Male
Societies, Medical
Child
Child Nutritional Physiological Phenomena
Colitis, Ulcerative
Europe
Female
Humans
Male
Societies, Medical
DeCS Terms
Ciencias de la Nutrición
Gastroenterología
Reservoritis
Cationes
Monitoreo de Drogas
Complejo de Antígeno L1 de Leucocito
Esteroides
Colectomía
Inseminación Artificial Heteróloga
Mesalamina
Gastroenterología
Reservoritis
Cationes
Monitoreo de Drogas
Complejo de Antígeno L1 de Leucocito
Esteroides
Colectomía
Inseminación Artificial Heteróloga
Mesalamina
CIE Terms
Keywords
anti-TNF, calprotectin, children, guidelines, inflammatorybowel disease-unclassified, management, mesalamine, monitoring,pediatrics, Pediatric Ulcerative Colitis Activity Index, thiopurines,treatment, ulcerative colitis, vedolizumab
Citation
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition [published correction appears in J Pediatr Gastroenterol Nutr. 2020 Dec;71(6):794]. J Pediatr Gastroenterol Nutr. 2018;67(2):257-291.